Evaluation of Transplacental Maternal SARS-CoV-2 Antibody Transfer in Small for Gestational Age Infants
Little is known about the potential benefits of maternal immunization in the setting of high-risk pregnancies resulting in small-for-gestational-age (SGA) infants. This study compares transplacental transfer of maternal SARS-CoV-2 anti-Spike antibody in pregnancies with SGA compared to appropriate-for-gestational-age infants.
Authors
- Alisa Kachikis (ORCID: https://orcid.org/0000-0003-0358-5107)
- Linda O. Eckert (ORCID: https://orcid.org/0000-0002-1357-8405)
- Alexander L. Greninger (ORCID: https://orcid.org/0000-0002-7443-0527)
- Erin A. Goecker
- Janet A. Englund (ORCID: https://orcid.org/0000-0003-1134-4178)
- Mindy Pike (ORCID: https://orcid.org/0000-0002-7153-868X)
- Emma A. Roberts (ORCID: https://orcid.org/0000-0001-5905-1716)
- Alexis Baranoff
- Michael G. Gravett
- Sharon Kung
Institutions
- Seattle Children's Hospital (US)
- University of San Diego (US)
- University of Washington (US)
- University of California San Diego (US)
- Seattle Children's Hospital (US)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1093/jpids/piae085
- Citations
- 2
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 1.17